Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
October 24, 2023 12:00 PM 5 min read

Assessing CME Gr's Performance Against Competitors In Capital Markets Industry

by Benzinga Insights Benzinga Staff Writer
Follow

In today's rapidly evolving and fiercely competitive business landscape, it is crucial for investors and industry analysts to conduct comprehensive company evaluations. In this article, we will undertake an in-depth industry comparison, assessing CME Gr (NASDAQ:CME) alongside its primary competitors in the Capital Markets industry. By meticulously examining crucial financial indicators, market positioning, and growth potential, we aim to provide valuable insights to investors and shed light on company's performance within the industry.

CME Gr Background

Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The CME was founded in 1898 and in 2002 completed its initial public offering. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival, CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX in 2018 it has also expanded into cash foreign exchange, fixed income trading, and collateral optimization.

When closely examining CME Gr, the following trends emerge:

Debt To Equity Ratio

The debt-to-equity (D/E) ratio is a measure that indicates the level of debt a company has taken on relative to the value of its assets net of liabilities.

Considering the debt-to-equity ratio in industry comparisons allows for a concise evaluation of a company's financial health and risk profile, aiding in informed decision-making.

By evaluating CME Gr against its top 4 peers in terms of the Debt-to-Equity ratio, the following observations arise:

  • CME Gr demonstrates a stronger financial position compared to its top 4 peers in the sector.

  • With a lower debt-to-equity ratio of 0.12, the company relies less on debt financing and maintains a healthier balance between debt and equity, which can be viewed positively by investors.

Key Takeaways

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
NewsMarketsTrading IdeasBZI-IA
CME Logo
CMECME Group Inc
$303.07-%
Overview
Company P/E P/B P/S ROE EBITDA (in billions) Gross Profit (in billions) Revenue Growth
CME Group Inc 26.11 2.76 14.65 2.78% $1.15 $1.15 9.94%
S&P Global Inc 49.32 3.14 9.44 1.42% $1.21 $2.08 3.61%
Intercontinental Exchange Inc 35.78 2.58 6.31 3.4% $1.29 $1.36 -3.19%
Moody's Corporation 39.83 18.03 10.29 12.49% $0.67 $1.07 8.18%
Nasdaq Inc 22.34 3.93 4.04 4.31% $0.44 $0.6 -7.67%
Tradeweb Markets Inc 52.66 3.40 14.36 1.75% $0.16 $0.21 4.53%
FactSet Research Systems Inc 35.88 10.16 8.05 3.96% $0.15 $0.27 1.13%
Morningstar Inc 415.81 7.75 4.98 2.96% $0.09 $0.29 7.29%
MarketAxess Holdings Inc 35.07 7.61 12.07 5.24% $0.1 $0.13 -1.31%
Donnelley Financial Solutions Inc 18.75 4.04 2 10.64% $0.07 $0.14 -9.05%
Open Lending Corp 17.64 3.50 5.13 5.35% $0.02 $0.03 -26.69%
Value Line Inc 17.60 3.81 8.25 5.74% $0.0 $0.01 -2.02%
Average 67.33 6.18 7.72 5.21% $0.38 $0.56 -2.29%
  • At 26.11, the stock's Price to Earnings ratio is 0.39x less than the industry average, suggesting favorable growth potential.

  • Considering a Price to Book ratio of 2.76, which is well below the industry average by 0.45x, the stock may be undervalued based on its book value compared to its peers.

  • The Price to Sales ratio of 14.65, which is 1.9x the industry average, suggests the stock could potentially be overvalued in relation to its sales performance compared to its peers.

  • The Return on Equity (ROE) of 2.78% is 2.43% below the industry average, suggesting potential inefficiency in utilizing equity to generate profits.

  • The Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) of $1.15 Billion is 3.03x above the industry average, highlighting stronger profitability and robust cash flow generation.

  • Compared to its industry, the company has higher gross profit of $1.15 Billion, which indicates 2.05x above the industry average, indicating stronger profitability and higher earnings from its core operations.

  • The company's revenue growth of 9.94% exceeds the industry average of -2.29%, indicating strong sales performance and market outperformance.

The PE, PB, and PS ratios for CME Gr indicate that the company's stock is undervalued compared to its peers in the Capital Markets industry. The low PE and PB ratios suggest that the stock is trading at a lower price relative to its earnings and book value. However, the high PS ratio indicates that the stock is trading at a higher price relative to its sales. In terms of profitability, CME Gr has a low ROE, indicating lower returns on shareholder equity compared to its peers. On the other hand, the company has high EBITDA, gross profit, and revenue growth, suggesting strong financial performance in terms of operating income and sales growth.

CME Logo
CMECME Group Inc
$303.07-%
Overview
Comments
Loading...